ChoA Pharmaceutical Co Ltd (034940) Stock Price & News

All values in KRW	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	13.64B	15.48B	15.82B	14.68B
Cost of goods sold	8.62B	9.75B	9.95B	9.51B
Cost of revenue	8.62B	9.75B	9.95B	9.51B
Research and development expenses	265.06M	275.94M	340.45M	158.07M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	6.06B	6.48B	6.61B	5.65B
Operating expense	6.53B	7.21B	7.37B	6.29B
Total operating expenses	15.14B	16.97B	17.32B	15.80B
Operating income	-1.50B	-1.49B	-1.50B	-1.12B
Other non operating income	106.04M	27.78M	173.15M	122.16M
EBT including unusual items	-1.51B	-414.59M	-2.30B	-149.94M
EBT excluding unusual items	-1.79B	-1.63B	-1.65B	-1.20B
Income tax expense	66.98M	-	872.67M	-
Effective tax rate	-4.43%	-	-38.02%	-
Other operating expenses	139.17M	192.66M	151.40M	131.64M
Net income	-1.42B	-273.95M	-3.06B	26.14M
Net profit margin	-10.38%	-1.77%	-19.37%	0.18%
Earnings per share	-	-	-	-
Interest and investment income	71.67M	21.69M	49.34M	24.78M
Interest expense	-282.06M	-306.90M	-327.44M	-303.43M
Net interest expenses	-210.39M	-285.20M	-278.10M	-278.64M
Depreciation and amortization charges	233.94M	237.53M	221.38M	219.13M
EBITDA	-901.74M	-870.05M	-842.60M	-585.02M
Gain or loss from assets sale	-246.68M	-1.20B	-92.97M	-1.00B

AI content may include mistakes. Learn more

Finance